Stay updated on Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial page.

Latest updates to the Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial page
- Check4 days agoChange DetectedAdded Araucania and Temuco, Araucania, Chile, 4800827. Added Bucharest; updated Temuco, Región de la Araucanía, Chile, 4800827 to Temuco, Araucania, Chile, 4800827 and București to Bucharest; revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedNapoli, Italy 80131 was replaced with Naples, Italy 80131 in the location list, and the revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check41 days agoChange DetectedThe study status was updated to Completed with a completion date of 2026-01-20; the previous Active, not recruiting status was removed.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check69 days agoChange DetectedRevision updated to v3.4.2. Previous revision v3.4.1 has been removed.SummaryDifference0.0%

- Check77 days agoChange DetectedRevision: v3.4.1 was added and v3.4.0 was removed, a minor internal update with no user-visible impact; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial page.